Company Canopus BioPharma Incorporated

Equities

Market Closed - OTC Markets Other stock markets 03:47:22 2024-05-31 pm EDT			5-day change	1st Jan Change
0.0004 ^USD	-.--%		-.--%	-.--%

2023	Canopus Biopharma Inc. Announces Amendment to its Original Distributor Partnership Beverage Agreement with PepsiCo, Inc	CI
2023	Canopus BioPharma Incorporated announced that it expects to receive $1 million in funding	CI

Managers	Title	Age	Since
Benjamin Oates CEO	Chief Executive Officer	-	22-02-16

Members of the board	Title	Age	Since
Benjamin Oates CEO	Chief Executive Officer	-	22-02-16

Name	Equities	%	Valuation
Mango Innovation LLC 3.437 %	80,000,000	3.437 %	40 000 $

Canopus Biopharma, Inc.

26 South Rio Grande Street Suite 2072

84043, Salt Lake City

This company's sector is not yet available